Current Studies
We are currently enrolling participants for the following studies:
Efficacy of REL-1017 as Adjunctive Treatment for Major Depressive Disorder
- Goal: Evaluation of the safety and effectiveness of REL-1017 with standard antidepressants.
Study of Women After Menopause Receiving Medication and/or Counseling for Depression
- Goal: Assessment of treatment outcomes in menopausal women.
Safety of COMP360 for Treatment-Resistant Depression
- Goal: Investigate the effects of COMP360 in people who haven’t responded to other treatments.
Inclusion Criteria
To qualify for our depression clinical trials, participants must meet certain criteria:
- Age: Usually between 18 and 75.
- Diagnosis: Must have a clinical diagnosis of depression.
- Treatment History: Requirements vary by study, with some needing previous treatment attempts.
What to Expect
- Initial Screening: A thorough evaluation will determine if you qualify.
- Study Participation: Depending on the study, you might need to attend multiple visits over several weeks or months.
- Monitoring: Our team will closely monitor your health throughout the study.
- Safety and Confidentiality: Your safety is our priority. All studies follow strict ethical guidelines and regulatory standards. We will keep your information confidential and securely handle any important data.
Frequently Asked Questions
What types of depression do your trials focus on?
Our research focuses on finding new therapies and improving current treatments for several forms of depression, including major depressive disorder (MDD), treatment-resistant depression, and postpartum depression.
Why should I participate in a depression clinical trial?
Participation may give you access to new therapies that are not yet available to the public, complete care overseen by experienced healthcare professionals, and the opportunity to advance science and improve future treatment options.
Which depression studies are currently enrolling?
We are currently enrolling for studies including an evaluation of REL-1017 as an adjunctive treatment for major depressive disorder, a study of women after menopause receiving medication and/or counseling for depression, and a study of COMP360 for treatment-resistant depression.
What are the inclusion criteria?
Participants are usually between 18 and 75 years old and must have a clinical diagnosis of depression. Treatment history requirements vary by study, with some requiring previous treatment attempts.
Volunteer Reviews
Google Based Reviews
A’m very grateful about this opportunity the staff are very professional and friendly I recommend AGA Clínica Research because they really help people to improve their lives thanks
~ Gladys Alvarez
I am very happy with the attention first of the doctor who is an excellent doctor, very kind, an excellent human being and the attention of his assistants such as the laboratory assistant..
~ Rosario Casais
Amazing service! The staff is very nice and patient with me and my family. I was seen right away. No wait time. Great experience!
~ Erika
Employees are very professional and friendly. Always able to convey the necessary information to the patient in the most accessible way.
~ Paola Allende
Very detailed and thorough in explaining. The office staff is friendly, warm and attentive.
~ Milerka Lantigua
Excellent service from the staff, the phlebotomist is very experienced and very good. The atmosphere is very pleasant and the coordinators are girls who are very attentive to everyone. The long time doctor is still here.
~ Dignora Ortega
Join Our Clinical Trials to Defeat the Depression
Help our researchers at AGA Clinical Trials advance the understanding and treatment of depression. Your participation can make a meaningful impact on the lives of many people dealing with this difficult condition. Call us at (786) 326-1583 for more details.